![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Schatz & Nobel Announce Lawsuit Against Cell Therapeutics
Schatz & Nobel Announce Lawsuit Against Cell Therapeutics
March 14, 2005
The law firm of Schatz & Nobel, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Western District of Washington on behalf of all persons who purchased the publicly traded securities of Cell Therapeutics between June 7, 2004, and March 4, 2005, inclusive.
Yahoo News (http://biz.yahoo.com/prnews/050311/phf034_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct